Pharma Mar SA
LSE:0RC6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharma Mar SA
LSE:0RC6
|
ES |
Wall St Price Targets
0RC6 Price Targets Summary
Pharma Mar SA
According to Wall Street analysts, the average 1-year price target for 0RC6 is 102.48 EUR with a low forecast of 63.51 EUR and a high forecast of 131.72 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RC6's stock price target?
Price Target
102.48
EUR
According to Wall Street analysts, the average 1-year price target for 0RC6 is 102.48 EUR with a low forecast of 63.51 EUR and a high forecast of 131.72 EUR.
What is the Revenue forecast for Pharma Mar SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for Pharma Mar SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is 17%.
What is the Operating Income forecast for Pharma Mar SA?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is 27%.
What is the Pre-Tax Income forecast for Pharma Mar SA?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 48%.
What is the Net Income forecast for Pharma Mar SA?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 8 years is 19%.
